ATE401894T1 - Verwendung von 15-keto-prostaglandin-e verbindungen als endothelin antagonisten - Google Patents
Verwendung von 15-keto-prostaglandin-e verbindungen als endothelin antagonistenInfo
- Publication number
- ATE401894T1 ATE401894T1 AT98953058T AT98953058T ATE401894T1 AT E401894 T1 ATE401894 T1 AT E401894T1 AT 98953058 T AT98953058 T AT 98953058T AT 98953058 T AT98953058 T AT 98953058T AT E401894 T1 ATE401894 T1 AT E401894T1
- Authority
- AT
- Austria
- Prior art keywords
- keto
- prostaglandin
- compounds
- endothelin antagonists
- endothelin
- Prior art date
Links
- VXPBDCBTMSKCKZ-XQHNHVHJSA-N 15-dehydro-prostaglandin E1 Chemical class CCCCCC(=O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O VXPBDCBTMSKCKZ-XQHNHVHJSA-N 0.000 title abstract 2
- 102000002045 Endothelin Human genes 0.000 title abstract 2
- 108050009340 Endothelin Proteins 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 title abstract 2
- 208000033386 Buerger disease Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000002308 endothelin receptor antagonist Substances 0.000 abstract 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP32783297 | 1997-11-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE401894T1 true ATE401894T1 (de) | 2008-08-15 |
Family
ID=18203488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98953058T ATE401894T1 (de) | 1997-11-28 | 1998-11-16 | Verwendung von 15-keto-prostaglandin-e verbindungen als endothelin antagonisten |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6197821B1 (de) |
| EP (1) | EP0978284B1 (de) |
| JP (1) | JP4319256B2 (de) |
| KR (1) | KR100648868B1 (de) |
| CN (1) | CN1206997C (de) |
| AT (1) | ATE401894T1 (de) |
| AU (1) | AU739343B2 (de) |
| CA (1) | CA2279267C (de) |
| DE (1) | DE69839767D1 (de) |
| DK (1) | DK0978284T3 (de) |
| ES (1) | ES2310013T3 (de) |
| NO (1) | NO328460B1 (de) |
| NZ (1) | NZ336960A (de) |
| PT (1) | PT978284E (de) |
| TW (1) | TW592701B (de) |
| WO (1) | WO1999027934A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003030912A1 (en) | 2001-08-31 | 2003-04-17 | Sucampo Ag | Prostaglandin analogs as chloride channel opener |
| TWI331920B (en) * | 2001-11-14 | 2010-10-21 | Sucampo Ag | Unit dosage form for relieving or treating constipation in human patients |
| TWI263505B (en) | 2001-11-19 | 2006-10-11 | Sucampo Ag | Pharmaceutical composition comprising a C1C-2 channel opener |
| JP4889219B2 (ja) * | 2002-12-27 | 2012-03-07 | スキャンポ・アーゲー | 腹部不快感の処置のためのプロスタグランジン誘導体 |
| US20040225014A1 (en) * | 2003-02-14 | 2004-11-11 | Sucampo Ag | Method for treating ocular hypertension and glaucoma |
| NZ556710A (en) * | 2005-01-27 | 2010-08-27 | Sucampo Ag | Method and composition for treating central nervous system disorders |
| NZ561414A (en) | 2005-03-04 | 2010-10-29 | Sucampo Ag | Method and composition for treating peripheral vascular diseases |
| CA2856659C (en) * | 2006-02-07 | 2015-09-22 | R-Tech Ueno, Ltd. | Prostaglandin derivatives |
| BRPI0708362A2 (pt) * | 2006-02-28 | 2011-05-24 | Sucampo Ag | método e composição para o tratamento de doença pulmonar obstrutiva crÈnica |
| MX2008013034A (es) * | 2006-04-13 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Antagonistas del receptor de endotelina para etapas tempranas de fibrosis pulmonar idiopatica. |
| US20080207759A1 (en) * | 2007-02-27 | 2008-08-28 | Sucampo Ag | Method for protecting mitochondria |
| US20090082442A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched lubiprostone |
| CN102050808B (zh) * | 2009-11-02 | 2014-03-12 | 上海天伟生物制药有限公司 | 一种前列腺素中间体的制备方法 |
| CA2784933A1 (en) * | 2009-12-18 | 2011-06-23 | Apotex Pharmachem Inc. | Processes for the purification of lubiprostone |
| CN104557845B (zh) * | 2015-01-13 | 2020-12-22 | 齐鲁制药有限公司 | 一种鲁比前列酮化合物的制备方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3853951A (en) | 1971-07-14 | 1974-12-10 | American Cyanamid Co | Preparation of 9-oxo-13-trans-prostenoic acid esters by alanate addition to cyclopentenone |
| US4018811A (en) | 1972-02-11 | 1977-04-19 | American Cyanamid Company | 3-Alkyl-2-(6-carboxyhexyl)cyclopentanones and esters and salts thereof |
| US3981868A (en) | 1973-05-31 | 1976-09-21 | American Cyanamid Company | Derivatives of 9-oxo-13-trans-prostenoic acid amides |
| CA1323364C (en) * | 1987-01-28 | 1993-10-19 | Ryuzo Ueno | Prostaglandins e and anti ulcer agents containing same |
| US5362751A (en) | 1988-05-11 | 1994-11-08 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Tracheobronchodilator using 16-substituted PGEs |
| JP2597649B2 (ja) * | 1988-05-11 | 1997-04-09 | 株式会社上野製薬応用研究所 | 気管・気管支拡張剤 |
| DE68906193T2 (de) * | 1988-05-23 | 1993-08-05 | Ueno Seiyaku Oyo Kenkyujo Kk | Hypersphyxia verursachende zusammensetzung. |
| JPH0232031A (ja) * | 1988-07-22 | 1990-02-01 | Nippon Steel Chem Co Ltd | イソプロピル化ｐ‐ターフェニル類の製造法 |
| CA2027814C (en) * | 1989-10-20 | 1996-07-30 | Ryuji Ueno | Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds |
| CA2030345C (en) * | 1989-11-22 | 1998-12-08 | Ryuji Ueno | Use of 15-keto-prostaglandin compound for improvement of encephalic function |
| CA2030346C (en) * | 1989-11-22 | 2000-04-11 | Ryuji Ueno | Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds |
| CA2030344C (en) * | 1989-11-22 | 2000-04-18 | Ryuji Ueno | Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds |
| TW249226B (de) | 1990-04-04 | 1995-06-11 | Aderk Ueno Kk | |
| ATE174221T1 (de) * | 1990-05-01 | 1998-12-15 | R Tech Ueno Ltd | Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten |
| CA2046069C (en) | 1990-07-10 | 2002-04-09 | Ryuji Ueno | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds |
| ES2093774T3 (es) | 1991-03-14 | 1997-01-01 | R Tech Ueno Ltd | Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina. |
| CN102126998B (zh) | 1996-06-10 | 2013-06-12 | 苏坎波公司 | 内皮素拮抗剂 |
| JPH107574A (ja) | 1996-06-17 | 1998-01-13 | R Tec Ueno:Kk | エンドセリン拮抗剤 |
-
1998
- 1998-11-16 DE DE69839767T patent/DE69839767D1/de not_active Expired - Lifetime
- 1998-11-16 NZ NZ336960A patent/NZ336960A/en not_active IP Right Cessation
- 1998-11-16 DK DK98953058T patent/DK0978284T3/da active
- 1998-11-16 KR KR1019997006752A patent/KR100648868B1/ko not_active Expired - Fee Related
- 1998-11-16 ES ES98953058T patent/ES2310013T3/es not_active Expired - Lifetime
- 1998-11-16 CA CA002279267A patent/CA2279267C/en not_active Expired - Fee Related
- 1998-11-16 PT PT98953058T patent/PT978284E/pt unknown
- 1998-11-16 US US09/355,270 patent/US6197821B1/en not_active Expired - Lifetime
- 1998-11-16 CN CNB988035863A patent/CN1206997C/zh not_active Expired - Fee Related
- 1998-11-16 WO PCT/JP1998/005143 patent/WO1999027934A1/ja not_active Ceased
- 1998-11-16 JP JP53056099A patent/JP4319256B2/ja not_active Expired - Fee Related
- 1998-11-16 AT AT98953058T patent/ATE401894T1/de active
- 1998-11-16 EP EP98953058A patent/EP0978284B1/de not_active Expired - Lifetime
- 1998-11-16 AU AU10537/99A patent/AU739343B2/en not_active Ceased
- 1998-11-17 TW TW087118975A patent/TW592701B/zh not_active IP Right Cessation
-
1999
- 1999-07-27 NO NO19993647A patent/NO328460B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2279267C (en) | 2010-01-12 |
| NZ336960A (en) | 2001-02-23 |
| KR100648868B1 (ko) | 2006-11-24 |
| EP0978284A1 (de) | 2000-02-09 |
| EP0978284B1 (de) | 2008-07-23 |
| NO993647D0 (no) | 1999-07-27 |
| KR20000070508A (ko) | 2000-11-25 |
| TW592701B (en) | 2004-06-21 |
| CN1251040A (zh) | 2000-04-19 |
| CA2279267A1 (en) | 1999-06-10 |
| JP4319256B2 (ja) | 2009-08-26 |
| AU739343B2 (en) | 2001-10-11 |
| ES2310013T3 (es) | 2008-12-16 |
| EP0978284A4 (de) | 2001-07-18 |
| US6197821B1 (en) | 2001-03-06 |
| NO328460B1 (no) | 2010-02-22 |
| NO993647L (no) | 1999-09-27 |
| CN1206997C (zh) | 2005-06-22 |
| DK0978284T3 (da) | 2008-10-27 |
| DE69839767D1 (de) | 2008-09-04 |
| PT978284E (pt) | 2008-10-07 |
| HK1025521A1 (en) | 2000-11-17 |
| WO1999027934A1 (fr) | 1999-06-10 |
| AU1053799A (en) | 1999-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE401894T1 (de) | Verwendung von 15-keto-prostaglandin-e verbindungen als endothelin antagonisten | |
| FI20030162A7 (fi) | Uusia yhdisteitä | |
| ATE100448T1 (de) | Substituierte chinazolinone als angiotensin iiantagonisten. | |
| DE69940063D1 (de) | Biphenylsulfonamide als zweifach aktive rezeptor antagonisten von angiotensin und endothelin | |
| CO4940465A1 (es) | Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol-3- il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona | |
| ATE464299T1 (de) | Neues phenylalaninderivat | |
| ATE305781T1 (de) | Non-peptidische vasopressin via antagonisten | |
| EA200000381A1 (ru) | Препарат 2-метил-тиено-бензодиазепина | |
| DE69714698D1 (de) | Endothelin-antagonisten | |
| ATE225351T1 (de) | Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel | |
| EA199901100A1 (ru) | Фармацевтические композиции, содержащие гемисульфат элетриптана и кофеин | |
| FR2799148B3 (fr) | Agrafeuse avec indication de la quantite d'agrafes restantes | |
| IT1293778B1 (it) | 1,4,7,10-tetraazabiciclo(8.2.2.)tetradecan-2 one, sua preparazione e suo uso per la preparazione di tetraazamacrocicli | |
| CY1106444T1 (el) | 17b-νιτρο-11β-αρυλοστepοειδη και παραγωγα αυτων ως ορμονικοι αγωνιστες ή ανταγωνιστες | |
| BR9813214A (pt) | Antagonista de receptor vitronectina | |
| ATE241360T1 (de) | Blutlipoproteinspiegel regulierendes präparat | |
| EA200000198A1 (ru) | 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов | |
| EA200200435A1 (ru) | Анализ лептина | |
| ATE257706T1 (de) | Endothelin antagonist und renin-angiotensin system hemmer als kombinationspräparate | |
| DE59808166D1 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum | |
| NO20000518L (no) | 2-acylaminopropanaminer som takykininreseptorantagonister | |
| ATE172205T1 (de) | Zyklische neurokinin a - antagonisten | |
| FI20010918A7 (fi) | Purkukynsi | |
| ID27964A (id) | Turuna-azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya | |
| ITRA970008U3 (it) | Acquisizione o digitalizzazione di strumenti urbanistici con l'ausilio di strumenti informatici hardware o software. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0978284 Country of ref document: EP |